I

IO Biotech

64 employees

IO Biotech is a clinical-stage biotech company developing disruptive immune therapies for the treatment of cancer.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics

Date founded

2015

Funding rounds raised

Total raised

$155M

from 12 investors over 12 rounds

I

IO Biotech raised $155M on January 13, 2021

Investors: Partner Fund Management, Soleus Capital Management, L.P., Novo Holdings, Sunstone Life Science Ventures, Vivo Capital, RA Capital Management, L.P. and Samsara BioCapital

I

IO Biotech raised $8.7M on May 12, 2020

Investors: Lundbeckfonden / Lundbeck Foundation, Sunstone Life Science Ventures and Novo Holdings

I

IO Biotech raised $12M on January 5, 2016

Investors: Lundbeckfonden / Lundbeck Foundation and Novo Nordisk Ltd

FAQ